Top accelerator startups

14,448 startups · 29 programs

Parallel Bio

Active · Using the immune system to cure disease

13signal of 100 · rising 3
  • team of 20Team size · YC's directory+6.9
  • went through YCProgram · this site+4
  • hiringHiring · Titles (titles.fru.dev), YC+2

A sum of public facts, not a judgement and not investment advice.

Competitors

Adjacent

Also from S21 in AI

All of S21

About Parallel Bio

Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of novel disease targets and drug candidates in both cancer and autoimmune disease, while collaborating with pharmaceutical companies to evaluate therapies directly in human systems to reduce the cost and risk of clinical trials. Based in San Francisco, the company was founded in 2021 by two of the world’s leading experts in replacing animal models with human-first platforms.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
AI
Team size
20
Location
San Francisco, CA, USA
Checked
10h ago

YC tags: AI-powered Drug Discovery, Biotech

Parallel Bio in S21: 391 companies, 34% AI

Parallel Bio: questions

Which YC batch was Parallel Bio in?

Parallel Bio was in Y Combinator's Summer 2021 batch (S21).

Is Parallel Bio still active?

Y Combinator lists Parallel Bio as active.

Where is Parallel Bio based?

Parallel Bio lists San Francisco, CA, USA as its location on YC's directory.